The target is a total phenytoin level of 15-20 ug/mL, or an estimated free phenytoin level of 1.5-2 ug/mL after albumin correction (more on this below)
these patients require more complex treatment and became a great challenge for gastroenterologists
Retrieved from: 3 "From molecules to milestones: Reinventing for the future of weight loss drugs," PwC
A 97/100 in True Cost Analysis reflects what might be the most honestly all-inclusive pricing model Ive reviewed: flat fees, no dose increases, no hidden charges, and a comprehensive support program that most clinics charge extra for
It is also worth noting that our comparison with topiramate, which shares a weight loss property, may partly reflect topiramates poor real-world tolerability and compliance rather than a true pharmacological advantage of GLP1 RAs. However, he also stated that the overall signal is encouraging and justifies further investigation